Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Influence of the GST, CYP and TP53 Gene Polymorphisms in the Risk of Graves' Disease and Its Outcome.

NCT00505011 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT00505011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00505011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Influence of the GST, CYP and TP53 Gene Polymorphisms in the Risk of Graves' Disease and Its Outcome.
Lead sponsor
University of Campinas, Brazil
Phase
Observational
Overall status
Completed
Start date
February 28, 1998
Completion date
February 28, 2007
Enrollment
1,998 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

graves' disease